Focus on New Drug Approvals. The FDA approved Vertex Pharmaceutical’s Suzetrigine (VX-548) for the treatment of moderate to severe acute pain in adults. Suzetrigine is a first-in-class non-opioid analgesic acting via blockade of the sodium channel Nav1.8.
Focus Biomolecules can supply Suzetrigine for research applications. Contact us for more information.
Website Created by Advanta Advertising LLC.
